UMED's World-First Automated Intermittent Bladder Irrigation System 'UroRinse®' Featured in Significant International Journal Following Successful Preclinical Study Collaborative Study with UCSD Proves Preventive Effect Against Catheter-Associated Urinary Tract Infections (CAUTIs)

UMED participated in the “2025 Startup-BuS Joint IR” event, where it shared its business strategy and technological vision.

UMED was selected for the 2025 Gyeongnam Startup Acceleration Support Program, recognizing its potential for global expansion.

UMED, based in Gimhae, is gaining attention in the medical device field by developing the automated bladder irrigation system ‘UroRinse’ through the Startup Leap Package.

Umed presented its collaboration achievements with Samsung Heavy Industries at the ‘2024 Startup Leap Package’ case-sharing event. The company was recognized for its technological capabilities and open innovation performance.

UMED has been selected as a target company for the corporate relocation project promoted by Ulsan City and Ulsan Technopark. As a technology-based small but strong enterprise, UMED is in the process of relocating to Ulsan.

UMED has been selected as one of the 10 leading technology innovation companies by the city of Gimhae.

UMED participated in the Gyeongnam High-Tech Zone IR Road Trip event, where the company presented its technology and received mentoring to attract investment.

UMED was founded by Professor Park Myungchan of Inje University and has been selected for a technology transfer commercialization program.

Filler-specialized company BioPlus (CEO Hyun-Gyu Jung) announced on the 26th that it had signed a memorandum of understanding (MOU) with urethral catheter specialist UroAll to jointly develop a medical device composed of a urethral catheter with drug-eluting capabilities and a drug called InterBlock to prevent re-stricture of the urethra.